Related Experiment Video
Updated: May 6, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.2K
Lymph node-positive bladder cancer: surgical, pathologic, molecular and prognostic aspects
Jose A Pedrosa1, Michael O Koch, Liang Cheng
1Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Expert Review of Anticancer Therapy
|October 19, 2013
Summary
Lymphatic metastasis worsens bladder cancer prognosis, but current staging is insufficient. New methods like lymph node density, extranodal extension, and molecular markers are crucial for better patient stratification and targeted therapies.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Lymphatic metastasis significantly impacts bladder cancer prognosis.
- Current tumor node metastasis staging is inadequate for stratifying patients with lymph node involvement.
- Pelvic lymph node dissection and detailed pathological assessment are recommended.
Purpose of the Study:
- To explore advanced methods for prognostic stratification in bladder cancer patients with positive lymph nodes.
- To highlight the limitations of current staging systems.
- To discuss emerging diagnostic and therapeutic strategies.
Main Methods:
- Review of current literature on prognostic factors in bladder cancer.
- Investigation of lymph node density and extranodal extension.
- Exploration of molecular markers for micrometastatic disease detection.
Main Results:
- Lymph node density and extranodal extension are significant prognostic indicators.
- Molecular markers show promise in diagnosing micrometastatic disease.
- Current staging systems do not fully capture prognostic variability.
Conclusions:
- Advanced pathological assessment and novel markers are essential for accurate bladder cancer prognosis.
- Targeted therapies show potential for improving outcomes in patients with lymph node metastasis.
- Further research is needed to integrate new findings into clinical practice.
